Skip to main content
Top

Respiratory Research

Issue 6/2001

Content (9 Articles)

Open Access Commentary

Obstructive sleep apnea and vascular disease

Paola Lanfranchi, Virend A Somers

Open Access Commentary

Impact of rhinitis on airway inflammation: biological and therapeutic implications

Giovanni Passalacqua, Giorgio Walter Canonica

Open Access Commentary

Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses

Kelan G Tantisira, Scott T Weiss

Open Access Review

Small airway inflammation in asthma

Meri K Tulic, Pota Christodoulopoulos, Qutayba Hamid

Open Access Review

Implications of post-pneumonectomy compensatory lung growth in pulmonary physiology and disease

Lynn M Brown, Stephen R Rannels, D Eugene Rannels

Open Access Review

The role of collagenase in emphysema

Robert Foronjy, Jeanine D'Armiento

Open Access Review

Surfactant alteration and replacement in acute respiratory distress syndrome

Andreas Günther, Clemens Ruppert, Reinhold Schmidt, Philipp Markart, Friedrich Grimminger, Dieter Walmrath, Werner Seeger

Open Access Research

Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific

Panos Pantelidis, Deirdre S McGrath, Anne Marie Southcott, Carol M Black, Roland M du Bois

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine